C-K Min

915 total citations
20 papers, 558 citations indexed

About

C-K Min is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, C-K Min has authored 20 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 7 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in C-K Min's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). C-K Min is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). C-K Min collaborates with scholars based in South Korea. C-K Min's co-authors include K-S Eom, YJ Kim, B-S Cho, W-S Min, Hyung Jun Kim, Dongwook Kim, JW Lee, Seok‐Goo Cho, C-C Kim and Se Lee and has published in prestigious journals such as Leukemia, Mucosal Immunology and Bone Marrow Transplantation.

In The Last Decade

C-K Min

18 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C-K Min South Korea 13 460 200 156 112 83 20 558
K-S Eom South Korea 13 442 1.0× 222 1.1× 135 0.9× 103 0.9× 73 0.9× 19 529
B-S Cho South Korea 13 408 0.9× 212 1.1× 116 0.7× 96 0.9× 72 0.9× 18 508
Josep Sarrà Spain 12 529 1.1× 297 1.5× 111 0.7× 144 1.3× 90 1.1× 25 623
Satoshi Nishiwaki Japan 15 458 1.0× 317 1.6× 166 1.1× 143 1.3× 92 1.1× 49 648
Sergey N. Bondarenko Russia 9 335 0.7× 132 0.7× 144 0.9× 112 1.0× 62 0.7× 117 466
Chong-Won Park South Korea 14 434 0.9× 105 0.5× 221 1.4× 126 1.1× 89 1.1× 38 619
Minako Iida Japan 7 290 0.6× 82 0.4× 105 0.7× 102 0.9× 78 0.9× 13 436
Jesse Levin United States 4 449 1.0× 59 0.3× 296 1.9× 111 1.0× 86 1.0× 6 558
Jean W. Bjerke United States 4 395 0.9× 97 0.5× 117 0.8× 79 0.7× 115 1.4× 5 417
T Furlong United States 7 296 0.6× 67 0.3× 136 0.9× 67 0.6× 48 0.6× 8 409

Countries citing papers authored by C-K Min

Since Specialization
Citations

This map shows the geographic impact of C-K Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C-K Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C-K Min more than expected).

Fields of papers citing papers by C-K Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C-K Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C-K Min. The network helps show where C-K Min may publish in the future.

Co-authorship network of co-authors of C-K Min

This figure shows the co-authorship network connecting the top 25 collaborators of C-K Min. A scholar is included among the top collaborators of C-K Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C-K Min. C-K Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ko, Hyun Soo, Se‐Young Choi, Sung Sup Park, et al.. (2025). Quantitative risk of underlying disease conditions for progression from monoclonal gammopathy to multiple myeloma: a nationwide cohort study. ESMO Open. 10(7). 105327–105327.
2.
Lee, Se, B-S Cho, K-S Eom, et al.. (2016). Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia. Bone Marrow Transplantation. 51(10). 1323–1329. 17 indexed citations
3.
Jeon, Young‐Woo, Je‐Hyun Yoon, Shin Sh, et al.. (2016). Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome. Bone Marrow Transplantation. 52(4). 522–531. 10 indexed citations
4.
Lee, Young‐Kyun, Se Lee, K-S Eom, et al.. (2015). MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease. Mucosal Immunology. 9(3). 730–743. 14 indexed citations
5.
Sh, Shin, Je‐Hyun Yoon, Se Lee, et al.. (2014). PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL. Bone Marrow Transplantation. 49(6). 773–779. 4 indexed citations
6.
Yoon, Joo‐Heon, Hyung Jun Kim, Jae Woo Kim, et al.. (2014). Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation. Bone Marrow Transplantation. 49(12). 1466–1474. 30 indexed citations
7.
Yoon, Joo‐Heon, W-S Min, Jae‐Hong Kim, et al.. (2013). Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?. Bone Marrow Transplantation. 48(12). 1562–1568. 17 indexed citations
8.
Lee, Seung‐Hwan, Dongwook Kim, B-S Cho, et al.. (2012). Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia. 26(11). 2367–2374. 80 indexed citations
9.
Sh, Shin, Joo‐Heon Yoon, Se Lee, et al.. (2012). Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure. Bone Marrow Transplantation. 48(5). 678–683. 12 indexed citations
10.
Lee, Se, B-S Cho, Jae‐Hoon Kim, et al.. (2012). Risk and prognostic factors for acute GVHD based on NIH consensus criteria. Bone Marrow Transplantation. 48(4). 587–592. 68 indexed citations
11.
Lee, SoJung, B-S Cho, K-S Eom, et al.. (2010). Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia. Leukemia. 24(12). 2110–2119. 19 indexed citations
12.
13.
Kim, Hyung Jun, W-S Min, B-S Cho, et al.. (2009). Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML. Bone Marrow Transplantation. 44(6). 345–351. 3 indexed citations
14.
Cho, B-S, C-K Min, K-S Eom, et al.. (2008). Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 41(9). 813–820. 56 indexed citations
15.
Cho, B-S, C-K Min, K-S Eom, et al.. (2008). Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia. 23(1). 78–84. 90 indexed citations
16.
Kim, Hyung Jun, W-S Min, K-S Eom, et al.. (2007). Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia. Bone Marrow Transplantation. 40(11). 1069–1074. 12 indexed citations
17.
Min, C-K, et al.. (2006). Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse. Bone Marrow Transplantation. 37(5). 493–498. 13 indexed citations
18.
Min, C-K, S Y Kim, Matthew J. Lee, et al.. (2006). Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation. Bone Marrow Transplantation. 38(2). 149–156. 49 indexed citations
19.
Lee, Suk, et al.. (2005). The Effect of the CT Number for Each CT on Dose Calculation.. 16(4). 161–165.
20.
Kim, YJ, Dongwook Kim, Sae-Mi Lee, et al.. (2004). Preemptive treatment of minimal residual disease post transplant in CML using real-time quantitative RT-PCR: a prospective, randomized trial. Bone Marrow Transplantation. 33(5). 535–542. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K-S Eom Breakdown of academic impact, for papers by B-S Cho Breakdown of academic impact, for papers by Josep Sarrà Breakdown of academic impact, for papers by Satoshi Nishiwaki Breakdown of academic impact, for papers by Sergey N. Bondarenko Breakdown of academic impact, for papers by Chong-Won Park Breakdown of academic impact, for papers by Minako Iida Breakdown of academic impact, for papers by Jesse Levin Breakdown of academic impact, for papers by Jean W. Bjerke Breakdown of academic impact, for papers by T Furlong
Rankless by CCL
2026